Patients undergo donor allogeneic pbsct involves. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

T-Lymphocytes Spleen Dendritic Cells Lymphocytes Hematopoietic Stem Cells T-Lymphocytes, Cytotoxic Cells, Cultured CD4-Positive T-Lymphocytes

Organisms6

Transplantation Chimera Mice, Inbred C57BL Mice, Inbred BALB C Radiation Chimera Mice, Inbred Strains Mice, Inbred C3H

Diseases17

Graft vs Host Disease Hematologic Neoplasms Leukemia Recurrence Leukemia, Myelogenous, Chronic, BCR-ABL Positive Anemia, Aplastic Leukemia, Myeloid, Acute Lymphoma, Non-Hodgkin Neoplasm, Residual Multiple Myeloma Precursor Cell Lymphoblastic Leukemia-Lymphoma Opportunistic Infections Infection Acute Disease Cytomegalovirus Infections Myelodysplastic Syndromes Hodgkin Disease

Chemicals and Drugs14

Isoantigens Granulocyte Colony-Stimulating Factor Cyclophosphamide Melphalan Antigens, CD34 Busulfan Immunosuppressive Agents HLA Antigens Vidarabine Carmustine Myeloablative Agonists Etoposide Cytarabine Histocompatibility Antigens

Analytical, Diagnostic and Therapeutic Techniques and Equipment33

Transplantation, Homologous Hematopoietic Stem Cell Transplantation Bone Marrow Transplantation Peripheral Blood Stem Cell Transplantation Transplantation Conditioning Transplantation, Autologous Transplantation, Isogeneic Lymphocyte Culture Test, Mixed Treatment Outcome Histocompatibility Testing Hematopoietic Stem Cell Mobilization Whole-Body Irradiation Combined Modality Therapy Skin Transplantation Stem Cell Transplantation Remission Induction Immunosuppression Retrospective Studies Lymphocyte Activation Survival Analysis Leukapheresis Antineoplastic Combined Chemotherapy Protocols Leukocyte Transfusion Lymphocyte Depletion Blood Component Removal Survival Rate Salvage Therapy Blood Transfusion Blood Transfusion, Autologous Matched-Pair Analysis Actuarial Analysis Follow-Up Studies Flow Cytometry

Psychiatry and Psychology1

Phenomena and Processes15

Graft Survival Histocompatibility Graft vs Tumor Effect Graft Rejection Graft vs Leukemia Effect Graft vs Host Reaction Transplantation Immunology Time Factors Lymphocyte Activation Cytotoxicity, Immunologic Radiation Chimera Immune Tolerance Transplantation Tolerance Chimerism Hematopoiesis

Anthropology, Education, Sociology and Social Phenomena1

Information Science1

Named Groups4

Tissue Donors Blood Donors Living Donors Siblings

Health Care8

Treatment Outcome Retrospective Studies Survival Analysis Survival Rate Matched-Pair Analysis Actuarial Analysis Tissue and Organ Procurement Follow-Up Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care

Transplantation, Homologous Hematopoietic Stem Cell Transplantation Tissue Donors Graft vs Host Disease Bone Marrow Transplantation Peripheral Blood Stem Cell Transplantation Blood Donors Transplantation Conditioning Living Donors Transplantation, Autologous Graft Survival Hematologic Neoplasms Transplantation, Isogeneic Transplantation Chimera Histocompatibility Isoantigens Lymphocyte Culture Test, Mixed Treatment Outcome T-Lymphocytes Graft vs Tumor Effect Leukemia Recurrence Histocompatibility Testing Hematopoietic Stem Cell Mobilization Granulocyte Colony-Stimulating Factor Whole-Body Irradiation Combined Modality Therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive Graft Rejection Skin Transplantation Stem Cell Transplantation Remission Induction Immunosuppression Cyclophosphamide Anemia, Aplastic Graft vs Leukemia Effect Retrospective Studies Graft vs Host Reaction Melphalan Transplantation Immunology Leukemia, Myeloid, Acute Time Factors Antigens, CD34 Lymphocyte Activation Lymphoma, Non-Hodgkin Survival Analysis Leukapheresis Busulfan Mice, Inbred C57BL Mice, Inbred BALB C Antineoplastic Combined Chemotherapy Protocols Leukocyte Transfusion Lymphocyte Depletion Immunosuppressive Agents Cytotoxicity, Immunologic Siblings Spleen Blood Component Removal HLA Antigens Radiation Chimera Neoplasm, Residual Survival Rate Multiple Myeloma Dendritic Cells Immune Tolerance Vidarabine Salvage Therapy Lymphocytes Carmustine Myeloablative Agonists Etoposide Transplantation Tolerance Precursor Cell Lymphoblastic Leukemia-Lymphoma Opportunistic Infections Blood Transfusion Cytarabine Infection Acute Disease Chimerism Blood Transfusion, Autologous Hematopoiesis Hematopoietic Stem Cells Matched-Pair Analysis T-Lymphocytes, Cytotoxic Cytomegalovirus Infections Actuarial Analysis Mice, Inbred Strains Histocompatibility Antigens Cells, Cultured Myelodysplastic Syndromes Hodgkin Disease Tissue and Organ Procurement Mice, Inbred C3H CD4-Positive T-Lymphocytes Follow-Up Studies Flow Cytometry

No FAQ available that match "patients undergo donor allogeneic pbsct involves"